Gozes I - Search Results

1

Ameliorative effect of NAP on laser-induced retinal damage.

Belokopytov M, Shulman S, Dubinsky G, Gozes I, Belkin M, Rosner M. Belokopytov M, et al. Among authors: gozes i. Acta Ophthalmol. 2011 Mar;89(2):e126-31. doi: 10.1111/j.1755-3768.2010.02041.x. Epub 2011 Feb 2. Acta Ophthalmol. 2011. PMID: 21288307 Free article.

2

A single administration of the peptide NAP induces long-term protective changes against the consequences of head injury: gene Atlas array analysis.

Romano J, Beni-Adani L, Nissenbaum OL, Brenneman DE, Shohami E, Gozes I. Romano J, et al. Among authors: gozes i. J Mol Neurosci. 2002 Feb-Apr;18(1-2):37-45. doi: 10.1385/JMN:18:1-2:37. J Mol Neurosci. 2002. PMID: 11931348

3

NAP accelerates the performance of normal rats in the water maze.

Gozes I, Alcalay R, Giladi E, Pinhasov A, Furman S, Brenneman DE. Gozes I, et al. J Mol Neurosci. 2002 Aug-Oct;19(1-2):167-70. doi: 10.1007/s12031-002-0028-0. J Mol Neurosci. 2002. PMID: 12212775

4

From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.

Gozes I, Divinsky I, Pilzer I, Fridkin M, Brenneman DE, Spier AD. Gozes I, et al. J Mol Neurosci. 2003;20(3):315-22. doi: 10.1385/JMN:20:3:315. J Mol Neurosci. 2003. PMID: 14501014 Review.

5

The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection.

Gozes I, Divinski I. Gozes I, et al. J Alzheimers Dis. 2004 Dec;6(6 Suppl):S37-41. doi: 10.3233/jad-2004-6s605. J Alzheimers Dis. 2004. PMID: 15665412

6

The expression of activity-dependent neuroprotective protein (ADNP) is regulated by brain damage and treatment of mice with the ADNP derived peptide, NAP, reduces the severity of traumatic head injury.

Gozes I, Zaltzman R, Hauser J, Brenneman DE, Shohami E, Hill JM. Gozes I, et al. Curr Alzheimer Res. 2005 Apr;2(2):149-53. doi: 10.2174/1567205053585873. Curr Alzheimer Res. 2005. PMID: 15974912

7

The influence of the peptide NAP on Mac-1-deficient mice following closed head injury.

Zaltzman R, Alexandrovich A, Trembovler V, Shohami E, Gozes I. Zaltzman R, et al. Among authors: gozes i. Peptides. 2005 Aug;26(8):1520-7. doi: 10.1016/j.peptides.2005.03.014. Epub 2005 Apr 15. Peptides. 2005. PMID: 16042992

8

Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate.

Gozes I, Spivak-Pohis I. Gozes I, et al. Curr Alzheimer Res. 2006 Jul;3(3):197-9. doi: 10.2174/156720506777632790. Curr Alzheimer Res. 2006. PMID: 16842095 Review.

9

Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.

Vulih-Shultzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, Gozes I. Vulih-Shultzman I, et al. Among authors: gozes i. J Pharmacol Exp Ther. 2007 Nov;323(2):438-49. doi: 10.1124/jpet.107.129551. Epub 2007 Aug 24. J Pharmacol Exp Ther. 2007. PMID: 17720885

10

NAP protects against cyanide-related microtubule destruction.

Zemlyak I, Sapolsky R, Gozes I. Zemlyak I, et al. Among authors: gozes i. J Neural Transm (Vienna). 2009 Nov;116(11):1411-6. doi: 10.1007/s00702-009-0252-7. Epub 2009 Jun 24. J Neural Transm (Vienna). 2009. PMID: 19551468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page